You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triple Negative Breast Cancer (TNBC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Camrelizumab Plus Chemotherapy and Famitinib
  • Camrelizumab Plus Chemotherapy
  • (no location specified)
Aug 17, 2023

Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

Not yet recruiting
  • Breast Cancer
  • Contrast Enhanced Ultrasound
  • Hershey, Pennsylvania
    Penn State Health College of Medicine
Jul 19, 2023

Breast Cancer Trial in Houston (Sacituzumab Govitecan, Pembrolizumab)

Not yet recruiting
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2022

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Atezolizumab + RP1
  • Paris, France
    Institut Curie
Oct 2, 2023

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

Not yet recruiting
  • Metastatic Triple-Negative Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
Aug 31, 2023

Triple Negative Breast Cancer Trial in Chengdu (Camrelizumab, Apatinib, Nab-paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Jul 6, 2022

Metastatic Triple-negative Breast Cancer Trial in Wuhan (Surufatinib, Tislelizumab)

Not yet recruiting
  • Metastatic Triple-negative Breast Cancer
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Feb 27, 2023

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
Oct 25, 2022

Metastatic Breast Cancer Trial in Shanghai (Sitravatinib, Tislelizumab, Nab-paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer
Jul 31, 2022

Triple Negative Breast Cancer (TNBC) Trial in El Segundo (Leucovorin, 5-Fluorouracil, Aldoxorubicin HCl)

Withdrawn
  • Triple Negative Breast Cancer (TNBC)
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Triple Negative Breast Cancer Trial (Ociperlimab, Tislelizumab, Paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • (no location specified)
Mar 30, 2023

Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Metastatic Breast Cancer
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Triple Negative Breast Cancer, Brain Metastases Trial in Saint Louis (Pembrolizumab, Liposomal Irinotecan)

Recruiting
  • Triple Negative Breast Cancer
  • Brain Metastases
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 1, 2022

Breast Cancer Trial in Amsterdam (Nivolumab, Radiation therapy, Low dose doxorubicin)

Active, not recruiting
  • Breast Cancer
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Mar 21, 2022

Triple Negative Breast Cancer (TNBC) Trial in United States (Combination of liposomal doxorubicin)

Not yet recruiting
  • Triple Negative Breast Cancer (TNBC)
  • Combination of liposomal doxorubicin
  • Elizabeth, New Jersey
  • +7 more
Jul 13, 2023

Metastatic Breast Cancer Trial in Amsterdam (Nivolumab, Cisplatin, Low dose doxorubicin)

Recruiting
  • Metastatic Breast Cancer
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Mar 21, 2022

Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

Recruiting
  • Leptomeningeal Disease
  • +2 more
  • Dendritic Cell Vaccine
  • Tampa, Florida
    Moffitt Cancer Center
Apr 11, 2023

Triple Negative Breast Cancer (TNBC) Trial in China (B013+Nab-Paclitaxel)

Recruiting
  • Triple Negative Breast Cancer (TNBC)
  • Guangzhou, Guangdong, China
  • +6 more
Jan 29, 2023

Immunotherapy-related CRP Kinetics in Early and Metastatic

Recruiting
  • TNBC - Triple-Negative Breast Cancer
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023

    Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

    Active, not recruiting
    • Edema
    • +8 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 23, 2023

    Triple Negative Breast Cancer Trial in Shanghai (Camrelizumab Plus Chemotherapy, +chemo)

    Recruiting
    • Triple Negative Breast Cancer
    • Camrelizumab Plus Chemotherapy
    • placebo+chemotherapy
    • Shanghai, China
      Fudan University Cancer Hospital
    Feb 9, 2022

    Breast Cancer Trial in Shanghai (ABX, cisplatin, Gemcitabine, Cisplatin)

    Completed
    • Breast Cancer
    • ABX, cisplatin
    • Gemcitabine, Cisplatin
    • Shanghai, China
      Fudan University Cancer Hospital
    Apr 20, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8

    Terminated
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • Bintrafusp Alfa
    • Eribulin Mesylate
    • Houston, Texas
    • +1 more
    Oct 27, 2022